The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.58BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Trailing P/E
38.77x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Revenue (TTM)
1.58BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
9.22%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Beta
0.5080x
vs all stocks
Updated Oct 28, 2026
52-Week Change
12.97%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
5.58BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
5.94BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Trailing P/E
38.77x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Forward P/E
20.43x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
PEG Ratio
2.13x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Price to Sales (TTM)
3.56x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Price to Book (MRQ)
3.35x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Enterprise to Revenue
3.76x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Enterprise to EBITDA
17.53x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.42×.Updated Oct 28, 2026
Gross Margin
51.37%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Profit Margin
9.22%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Operating Margin
14.46%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Return on Assets (TTM)
4.92%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Return on Equity (TTM)
9.19%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Revenue (TTM)
1.58BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
26.56USDUpdated Oct 28, 2026
Quarterly Revenue Growth
9.50%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Gross Profit (TTM)
781.73MUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
361.89MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
145.56MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Quarterly Earnings Growth (YoY)
19.10%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Operating Cash Flow (TTM)
283.45MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Levered Free Cash Flow (TTM)
173.90MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Revenue
1.52BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
777.64MUSDFY2025 · Dec 31, 2025
Gross Profit
738.27MUSDFY2025 · Dec 31, 2025
Operating Income
185.70MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
170.94MUSDFY2025 · Dec 31, 2025
Income Tax Expense
42.45MUSDFY2025 · Dec 31, 2025
Net Income
128.49MUSDFY2025 · Dec 31, 2025
EBIT
197.40MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
333.03MUSDFY2025 · Dec 31, 2025
Research & Development
97.35MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
455.21MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
15.07MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
26.46MUSDFY2025 · Dec 31, 2025
EPS (Basic)
2.17USDFY2025 · Dec 31, 2025
EPS (Diluted)
2.13USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
59.16MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
59.16MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
128.49MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
279.64MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
448.55MUSDFY2025 · Dec 31, 2025
Income Tax Paid
31.39MUSDFY2025 · Dec 31, 2025
Interest Paid
20.99MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
128.49MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
134.65MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
5.21MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
43.46MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
6.54MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-2.73MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
1.01MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-36.99MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-144.77MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-17.78MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-162.55MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-12.21MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
16.00MUSDFY2025 · Dec 31, 2025
Shares Outstanding
59.71MSharesUpdated Oct 28, 2026
Float Shares
58.30MSharesUpdated Oct 28, 2026
Shares Short
3.63MSharesUpdated Oct 28, 2026
Short Ratio
5.93days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
8.22%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 6.08%.Updated Oct 28, 2026
% Held by Insiders
2.45%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
108.02%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
448.70MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
7.51USDUpdated Oct 28, 2026
Total Debt (MRQ)
820.12MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
0.4882x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Current Ratio (MRQ)
4.20x
vs Medical Instruments & Supplies peers
Updated Oct 28, 2026
Book Value per Share (MRQ)
28.13USDUpdated Oct 28, 2026
Total Assets
2.69BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.04BUSDFY2025 · Dec 31, 2025
Total Liabilities
1.10BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
1.65BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
861.86MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
239.76MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
446.40MUSDFY2025 · Dec 31, 2025
Accounts Receivable
203.71MUSDFY2025 · Dec 31, 2025
Inventory
333.70MUSDFY2025 · Dec 31, 2025
Accounts Payable
60.55MUSDFY2025 · Dec 31, 2025
Short-term Debt
10.88MUSDFY2025 · Dec 31, 2025
Deferred Revenue
247.00KUSDFY2025 · Dec 31, 2025
Long-term Debt
810.70MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
12.55MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
763.91MUSDFY2025 · Dec 31, 2025
Retained Earnings
824.03MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.58BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
59.74USDUpdated Oct 28, 2026
52-Week High
94.85USDUpdated Oct 28, 2026
52-Week Change
12.97%
vs all stocks
Updated Oct 28, 2026
Beta
0.5080x
vs all stocks
Updated Oct 28, 2026
50-Day MA
88.45USDUpdated Oct 28, 2026
200-Day MA
76.77USDUpdated Oct 28, 2026
Avg 10-Day Volume
675.40KSharesUpdated Oct 28, 2026
Avg 30-Day Volume
620.46KSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
2.43USDUpdated Oct 28, 2026
Other Income / Expense
-3.38MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.64: safe zoneNotable
Altman Z-Score: 4.64
High earnings qualityNotable
Earnings Quality Score: 1.36
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $5.58B, above the global median of $1.14BNotable
Market cap (USD): 5,584,715,582Global Median: 1,137,180,293.291
Revenue is $1.58B, above the global median of $566.17MNotable